Microscopic surgical stage IIIc endometrioid adenocarcinoma of the endometrium: Implications for bimodal adjuvant therapy

International Journal of Gynecological Cancer

Volumn 8, Issue 1, 1998, Pages 41-45

  Faught, W ^a   Fung, M Fung Kee ^a   Krepart, G V ^b   Lotocki, R J ^b,c   Heywood, M S ^b,c,d   Genest, P ^e  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CANCERCARE MANITOBA   (Canada)

^c ST BONIFACE GENERAL HOSPITAL   (Canada)

^d Womens Hospital   (Canada)

^e OTTAWA REGIONAL CANCER CENTRE   (Canada)

Author keywords

Adenocarcinoma; Adjuvant therapy; Chemotherapy; Endometrium

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; HUMAN; PRIORITY JOURNAL;

EID: 0031934876     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Barakat RR, Park RC, Grigsby PW, Muss HD, Norris HJ. Corpus: Epithelial Tumors. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology, 2nd ed. Philadelphia: Lippincott-Raven, 1997: 859-96.
2. Creasman WT. New gynecologic cancer staging. Obstet Gynecol 1990; 75: 287-8.
3. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study. Cancer Supplement 1987; 60: 2035-41.
4. Wolfson AH, Sightler SE, Markoe AM, et al. The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol 1992; 45: 142-6.
5. Burke TW, Stringer CA, Morris M, et al. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Gynecol Oncol 1991; 40: 264-7.
6. Potish RA, Twiggs LB, Adcock LL, Savage JE, Levitt SH, Prem KA. Paraaortic lymph node radiotherapy in cancer of the uterine corpus. Obstet Gynecol 1985; 65: 251-6.
7. Muss HB. Chemotherapy of metastatic endometrial cancer. Semin Oncol 1994; 21: 107-13.
8. Rotman M, Aziz H, Halpern J, Schwartz D, Sohn C, Choi K. Endometrial carcinoma. Cancer Supplement 1993; 71: 1471-9.
9. Bruckman JE, Bloomer WD, Marck A, Ehrmann RL, Knapp RC. Stage III adenocarcinoma of the endometrium: two prognostic groups. Gynecol Oncol 1980; 9: 12-7.
10. Greven KM, Lanciano RM, Corn B, Case D, Randall ME. Pathologic stage III endometrial carcinoma. Cancer 1993; 71: 3697-702.
11. Schorge JO, Molpus KL, Goodman A, Nikrui N, Fuller AF. The effect of postsurgical therapy on stage III endometrial carcinoma. Gynecol Oncol 1996; 63: 34-9.
12. DiSaia PJ, Creasman WT. Appendix C: Gynecologic Oncology Group Common Toxicity Criteria Grade-October 1988. In: Manning S, ed. Clinical Gynecologic Oncology, 4th ed. St. Louis: Mosby-Year Book. 1993; 710-5.
13. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
14. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet Gynecol 1980; 56: 419-26.
15. Piver MS, Hempling RE. A prospective trial of postoperative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma. Cancer 1990; 66: 1133-8.
16. Cowles TA, Magrina JF, Masterson BJ, Capen CV. Comparison of clinical and surgical staging in patients with endometrial carcinoma. Obstet Gynecol 1985; 66: 413-6.
17. Kadar N, Malfetano JH, Homesley HD. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy. Obstet Gynecol 1992; 80: 655-9.